Ferrous Fumarate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14491 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | non-syndromic esophageal malformation | KG + DL |
| 2 | esophageal disease | KG + DL |
| 3 | esophageal ulcer | KG + DL |
| 4 | Plummer-Vinson syndrome | KG + DL |
| 5 | vitamin B12- and folate-independent constitutional megaloblastic anemia | KG + DL |
| 6 | injury | KG + DL |
| 7 | perinatal disease | KG + DL |
| 8 | segmental odontomaxillary dysplasia | KG + DL |
| 9 | florid cemento-osseous dysplasia | KG + DL |
| 10 | disease by subcellular system affected | KG + DL |
| 11 | radiation or chemically induced disorder | KG + DL |
| 12 | cell proliferation disorder | KG + DL |
| 13 | iatrogenic disease | KG + DL |
| 14 | regional odontodysplasia | KG + DL |
| 15 | biotin metabolic disease | KG + DL |
| 16 | macular dystrophy with central cone involvement | KG + DL |
| 17 | vitamin deficiency disorder | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.